Our Stories
Latest News
Innovation
Caring & Giving
Personal Stories
Health & Wellness
Our Heritage
Our Company
About J&J
Our Credo
Our Leadership Team
Corporate Governance
Diversity & Inclusion
Empowering Women
Innovation at J&J
Office of the Chief Medical Officer
J&J Health and Wellness Solutions
Policies & Statements
Code of Business Conduct
Corporate Reports
Products
Consumer Products
Medical Devices
Pharmaceutical Products
Procurement
Value Pillars
Supplier Diversity
Supplier Standards
Careers
What We Do
How We Hire
Job Spotlight
Employee Benefits
Students
Innovation
Career Stories
Media Center
Investors
Corporate Governance
Quarterly Results
SEC Filings
News Releases
Pharmaceutical Pipeline
2016 Health for Humanity Report
Stock Information
Webcasts & Presentations
Our Societal Impact
Global Community Impact
Global Public Health
Global Environmental Health
Citizenship & Sustainability Reporting
Follow Us
Facebook
Twitter
YouTube
LinkedIn
Explore more Johnson & Johnson sites:
Australia
Argentina
Brazil
Canada
Chile
China
Colombia
Costa Rica
Ecuador
Germany
India
Italy
Japan
Mexico
New Zealand / Pacific
Paraguay
Peru
Philippines
Russia
Switzerland
German
English
French
Italian
Uruguay
United States
Venezuela
Press Release Archive
+
View Filters
All Topics
Caring & Giving
Health & Wellness
Innovation
Our Company
Our Heritage
Our Products
All Dates
Last 30 Days
Last 90 Days
Last Year
Sort by Newest
Sort by Oldest
Products & Operating Company
September 17, 2014
DePuy Synthes Announces Agreement with Blue Belt Technologies, Inc. Agreement enables access to the SIGMA® HP Partial Knee on the Navio™ Surgical System
Products & Operating Company
September 12, 2014
Johnson & Johnson Announces New Grant to Harvard Medical School to Combat Drug-Resistant Tuberculosis
New collaboration will help address significant global unmet needs in pediatric drug-resistant tuberculosis (DR-TB) treatment and optimize use of existing DR-TB treatments
September 10, 2014
Cordis Corporation Launches INCRAFT® AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms (AAA)
Innovative AAA Device Offers New, Less Invasive Option for Patients and Physicians
Corporate
September 03, 2014
Johnson & Johnson to Participate in 2014 Morgan Stanley Health Care Conference
September 03, 2014
Johnson & Johnson Responds to Ebola Crisis with Commitment to Accelerate Vaccine Program in Collaboration with the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
Products & Operating Company
September 02, 2014
New Data Show Once-Daily XARELTO® May Be an Alternative to Vitamin K Antagonists in Treating Atrial Fibrillation Patients Undergoing Elective Cardioversion
X-VeRT Study Results Presented as a Hot Line Session at the ESC Congress 2014 and Published in European Heart Journal
Products & Operating Company
August 29, 2014
Janssen Expands EXPLORER Global Cardiovascular Research Program to Evaluate the Role of XARELTO® in Addressing Critical Medical Needs
New Studies Grow XARELTO® Clinical Development Program to More Than 275,000 Patients
Products & Operating Company
August 26, 2014
Janssen Diagnostics Expands Research Portfolio to Include Next-Generation Sequencing
Enhanced Offering to Enable ‘Dynamic Monitoring’ in Cancer Research
Products & Operating Company
August 26, 2014
Ethicon Expands Bariatric Surgery Portfolio; Unveils “Evidence Corner” At IFSO To Address Obesity And Metabolic Diseases
Highlights New Stapler System and Advanced Energy Devices, and Provides Forum for New Evidence Generation
Products & Operating Company
August 25, 2014
Janssen Affiliate Cilag GmbH International Acquires Covagen AG
Clinical Candidate COVA 322 and FynomAb® Technology Platform Further Strengthen Immunology Portfolio and Capabilities
See More Press Releases